Current research on NFE2L3 in renal cancer has primarily focused on analyzing sequencing data (Wang et al., 2019; Zhang et al., 2020; Bai et al., 2021; Zhang et al., 2022). This evidence concerns the gene NFE2L3 and renal carcinoma.